USD 25.72
(1.94%)
Year | Revenue | Revenue Growth |
---|---|---|
2024 | 356.29 Million USD | 26.84% |
2023 | 280.91 Million USD | 31.74% |
2022 | 213.23 Million USD | 43.42% |
2021 | 148.67 Million USD | 19.15% |
2020 | 124.78 Million USD | 24.92% |
2019 | 99.88 Million USD | 25.12% |
2018 | 79.83 Million USD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q4 | 95 Million USD | 3.7% |
2024 FY | 356.29 Million USD | 26.84% |
2024 Q3 | 91.61 Million USD | 6.74% |
2024 Q1 | 83.84 Million USD | 9.48% |
2024 Q2 | 85.83 Million USD | 2.37% |
2023 Q3 | 73.1 Million USD | 7.72% |
2023 Q2 | 67.86 Million USD | 7.12% |
2023 FY | 280.91 Million USD | 31.74% |
2023 Q1 | 63.35 Million USD | 9.19% |
2023 Q4 | 76.58 Million USD | 4.76% |
2022 Q2 | 51 Million USD | 5.62% |
2022 Q1 | 48.29 Million USD | 15.51% |
2022 Q3 | 55.91 Million USD | 9.62% |
2022 FY | 213.23 Million USD | 43.42% |
2022 Q4 | 58.02 Million USD | 3.76% |
2021 Q2 | 35 Million USD | 4.83% |
2021 Q1 | 33.39 Million USD | 1.77% |
2021 Q3 | 38.46 Million USD | 9.87% |
2021 Q4 | 41.8 Million USD | 8.69% |
2021 FY | 148.67 Million USD | 19.15% |
2020 FY | 124.78 Million USD | 24.92% |
2020 Q3 | 32.84 Million USD | 6.58% |
2020 Q4 | 32.81 Million USD | -0.09% |
2020 Q2 | 30.81 Million USD | 8.85% |
2020 Q1 | 28.3 Million USD | 6.9% |
2019 FY | 99.88 Million USD | 25.12% |
2019 Q4 | 26.48 Million USD | 6.98% |
2019 Q1 | 23.87 Million USD | 0.0% |
2019 Q2 | 24.77 Million USD | 3.8% |
2019 Q3 | 24.75 Million USD | -0.09% |
2018 FY | 79.83 Million USD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
American Well Corporation | 259.04 Million USD | -37.542% |
Doximity, Inc. | 475.42 Million USD | 25.056% |
Evolent Health, Inc. | 1.96 Billion USD | 81.858% |
MultiPlan Corporation | 961.52 Million USD | 62.944% |
Teladoc Health, Inc. | 2.6 Billion USD | 86.309% |
Veeva Systems Inc. | 2.36 Billion USD | 84.926% |